In 2018-2019, Vietnam continued to witness high-value mergers and acquisitions transactions in a variety of sectors, such as food manufacturing, real estate, banking, and retail.
Vietnam's high and steady economic growth in the past years has strongly drawn foreign capital and investment in local firms, considered as the shortest way for foreign investors to enter the Vietnamese market.
Japan’s Taisho Pharmaceutical Co Ltd has proposed increasing its ownership in DHG Pharmaceutical Joint Stock Company by 21.7 percent.
Vietnam’s pharmaceutical market continues to be a lucrative industry, evidenced by the huge profits reaped by leading drug makers in this year’s first nine months, despite increasingly fierce competition from foreign rivals.
Vietnam’s mergers-and-acquisitions market has the potential to draw more Asian investors to a growing pool, as they search for opportunities away from slowing domestic markets. However, there need to be more high-quality share offerings if Vietnam wants to spur them into action.
Pharma stocks have continue rising, as drug firms are expected to lift their foreign ownership limits and collaborate with overseas partners.